Literature DB >> 27845236

Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis.

Kohei Hasegawa1, Jonathan M Mansbach2, Nadim J Ajami3, Joseph F Petrosino3, Robert J Freishtat4, Stephen J Teach4, Pedro A Piedra5, Carlos A Camargo6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27845236      PMCID： PMC5385272          DOI： 10.1016/j.jaci.2016.09.037

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

Review 1.  Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.

Authors:  Ashley L Hilchie; Kelli Wuerth; Robert E W Hancock
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

2.  The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps.

Authors:  Ariane Neumann; Evelien T M Berends; Andreas Nerlich; E Margo Molhoek; Richard L Gallo; Timo Meerloo; Victor Nizet; Hassan Y Naim; Maren von Köckritz-Blickwede
Journal:  Biochem J       Date:  2014-11-15       Impact factor: 3.857

3.  Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Authors:  Shawn L Ralston; Allan S Lieberthal; H Cody Meissner; Brian K Alverson; Jill E Baley; Anne M Gadomski; David W Johnson; Michael J Light; Nizar F Maraqa; Eneida A Mendonca; Kieran J Phelan; Joseph J Zorc; Danette Stanko-Lopp; Mark A Brown; Ian Nathanson; Elizabeth Rosenblum; Stephen Sayles; Sinsi Hernandez-Cancio
Journal:  Pediatrics       Date:  2014-11       Impact factor: 7.124

4.  Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Nadim J Ajami; Janice A Espinola; David M Henke; Joseph F Petrosino; Pedro A Piedra; Chad A Shaw; Ashley F Sullivan; Carlos A Camargo
Journal:  Eur Respir J       Date:  2016-10-06       Impact factor: 16.671

5.  Cathelicidin Antimicrobial Peptide: A Novel Regulator of Islet Function, Islet Regeneration, and Selected Gut Bacteria.

Authors:  Lynley D Pound; Christopher Patrick; Chandra E Eberhard; Walid Mottawea; Gen-Sheng Wang; Turki Abujamel; Roxanne Vandenbeek; Alain Stintzi; Fraser W Scott
Journal:  Diabetes       Date:  2015-09-14       Impact factor: 9.461

6.  Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia.

Authors:  Melissa A Kovach; Megan N Ballinger; Michael W Newstead; Xianying Zeng; Urvashi Bhan; Fu-shin Yu; Bethany B Moore; Richard L Gallo; Theodore J Standiford
Journal:  J Immunol       Date:  2012-05-25       Impact factor: 5.422

7.  Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.

Authors:  Wouter A A de Steenhuijsen Piters; Santtu Heinonen; Raiza Hasrat; Eleonora Bunsow; Bennett Smith; Maria-Carmen Suarez-Arrabal; Damien Chaussabel; Daniel M Cohen; Elisabeth A M Sanders; Octavio Ramilo; Debby Bogaert; Asuncion Mejias
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

8.  Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota.

Authors:  Jonathan M Mansbach; Kohei Hasegawa; David M Henke; Nadim J Ajami; Joseph F Petrosino; Chad A Shaw; Pedro A Piedra; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2016-04-06       Impact factor: 10.793

9.  Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Niels Borregaard; Adrian R Martineau; Mark I Neuman; Janice A Espinola; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2012-09-01       Impact factor: 10.793

10.  The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx.

Authors:  R L Marsh; M Kaestli; A B Chang; M J Binks; C E Pope; L R Hoffman; H C Smith-Vaughan
Journal:  Microbiome       Date:  2016-07-07       Impact factor: 14.650
  10 in total
  21 in total

1.  Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Yury A Bochkov; James E Gern; Pedro A Piedra; Cindy S Bauer; Stephen J Teach; Susan Wu; Ashley F Sullivan; Carlos A Camargo
Journal:  JAMA Pediatr       Date:  2019-06-01       Impact factor: 16.193

Review 2.  Viral Bacterial Interactions in Children: Impact on Clinical Outcomes.

Authors:  Alejandro Diaz-Diaz; Cristina Garcia-Maurino; Alejandro Jordan-Villegas; Jeffrey Naples; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

3.  Associations of Nasopharyngeal Metabolome and Microbiome with Severity among Infants with Bronchiolitis. A Multiomic Analysis.

Authors:  Christopher J Stewart; Jonathan M Mansbach; Matthew C Wong; Nadim J Ajami; Joseph F Petrosino; Carlos A Camargo; Kohei Hasegawa
Journal:  Am J Respir Crit Care Med       Date:  2017-10-01       Impact factor: 21.405

4.  The relationship between nasopharyngeal CCL5 and microbiota on disease severity among infants with bronchiolitis.

Authors:  K Hasegawa; J M Mansbach; N J Ajami; J F Petrosino; R J Freishtat; S J Teach; P A Piedra; C A Camargo
Journal:  Allergy       Date:  2017-04-12       Impact factor: 13.146

Review 5.  Bacterial microbiota of the nasal passages across the span of human life.

Authors:  Lindsey Bomar; Silvio D Brugger; Katherine P Lemon
Journal:  Curr Opin Microbiol       Date:  2017-11-20       Impact factor: 7.934

Review 6.  Childhood Asthma: Is It All About Bacteria and Not About Viruses? A Pro/Con Debate.

Authors:  Avraham Beigelman; Christian Rosas-Salazar; Tina V Hartert
Journal:  J Allergy Clin Immunol Pract       Date:  2018-01-12

7.  RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFκB signaling.

Authors:  Kohei Hasegawa; Marcos Pérez-Losada; Claire E Hoptay; Samuel Epstein; Jonathan M Mansbach; Stephen J Teach; Pedro A Piedra; Carlos A Camargo; Robert J Freishtat
Journal:  Pediatr Res       Date:  2018-01-17       Impact factor: 3.756

8.  Severe bronchiolitis profiles and risk of recurrent wheeze by age 3 years.

Authors:  Orianne Dumas; Kohei Hasegawa; Jonathan M Mansbach; Ashley F Sullivan; Pedro A Piedra; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2018-09-18       Impact factor: 10.793

9.  Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease.

Authors:  Aran Singanayagam; Nicholas Glanville; Leah Cuthbertson; Nathan W Bartlett; Lydia J Finney; Elena Turek; Eteri Bakhsoliani; Maria Adelaide Calderazzo; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Phillip L James; Peter Fenwick; Samuel V Kemp; Thomas B Clarke; Jadwiga A Wedzicha; Michael R Edwards; Miriam Moffatt; William O Cookson; Patrick Mallia; Sebastian L Johnston
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

10.  Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology.

Authors:  Jonathan M Mansbach; Kohei Hasegawa; Nadim J Ajami; Joseph F Petrosino; Pedro A Piedra; Courtney N Tierney; Janice A Espinola; Carlos A Camargo
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.